RxDoctor Payments Data

Susan Harvey, MD

Anatomic Pathology & Clinical Pathology · Alabaster, ALNPI 1366436941

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 7 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 26.1% of the total. Reporting peaked in 2023 at $49 and has fallen 69.7% since, to $15 in 2025.

$112in general payments, 2019–2025

Across 7 payments — averaging $16.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$29
  • Ardelyx, Inc.$29
  • Gilead$22
  • AbbVie$16
  • Aimmune Therapeutics, Inc.$16

What the payments were for

  • Food & beverage$112100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$112 in reported general payments places this provider in the 60th percentile of 115 anatomic pathology & clinical pathology providers in Alabama.

See all anatomic pathology & clinical pathology providers in Alabama

Medicare billing

Part B allowed, 2024
$276,791
Medicare patients
1,844
Services billed
4,466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Alabaster

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →